Product Name: Human IGF1R / CD221 Antibody (Robatumumab, Research Use)
Catalog Number: NBR-0852
Target Name: IGF1R / CD221
Trade Name: Robatumumab
Antibody Drug Description: Robatumumab, also known as SCH 717454 and MK-7454, is a monoclonal antibody developed by Merck and Schering-Plough and act as an antineoplastic agent. It binds to the insulin-like growth factor 1 receptor (IGF-1R) with very high affinity. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: IGF1R
Synonyms: CD221; IGFIR; IGFR; JTK13; MGC18216
Target Description: Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1). Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity.
Ensembl: ENSG00000140443
Uniprot: P08069